VOYA Investment Management
AVBP icon

VOYA Investment Management’s ArriVent BioPharma AVBP Stock Holding History

VOYA Investment Management’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$611K Buy
17,579
+2,248
+15% +$66.3K ﹤0.01% 1723
2026
Q1 		$354K Buy
+15,331
New +$346K ﹤0.01% 1877
2025
Q1 		– Sell
-8,373
Closed -$223K – 2736
2024
Q4 		$223K Buy
+8,373
New +$240K ﹤0.01% 2345

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

VOYA Investment Management's AVBP Position: Q2 2026 in Review

VOYA Investment Management increased its ArriVent BioPharma (AVBP) stake by 15% in Q2 2026, buying an estimated $66.3K and bringing the position to 17,579 shares worth $611K. The position accounts for ﹤0.01% of the portfolio, ranked #1723.

VOYA Investment Management first reported a position in AVBP in Q4 2024 and has held it in 3 quarters since. 157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • VOYA Investment Management held 17,579 shares of ArriVent BioPharma worth $611K as of Q2 2026.
  • VOYA Investment Management bought 2,248 ArriVent BioPharma shares in Q2 2026, an estimated $66.3K.
  • ArriVent BioPharma made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1723 holding.
  • VOYA Investment Management first reported a position in ArriVent BioPharma in Q4 2024 and has held it in 3 quarters since.
  • 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.